Cargando…

High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment

Antifibrotic treatment slows down functional decline and disease progression in idiopathic pulmonary fibrosis (IPF). High-resolution computed tomography (HRCT) is useful to diagnose IPF; however, little is known about whether and to what extent HRCT changes reflect functional changes during antifibr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balestro, Elisabetta, Cocconcelli, Elisabetta, Giraudo, Chiara, Polverosi, Roberta, Biondini, Davide, Lacedonia, Donato, Bazzan, Erica, Mazzai, Linda, Rizzon, Giulia, Lococo, Sara, Turato, Graziella, Tinè, Mariaenrica, Cosio, Manuel G., Saetta, Marina, Spagnolo, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780456/ https://www.ncbi.nlm.nih.gov/pubmed/31540181 http://dx.doi.org/10.3390/jcm8091469

Ejemplares similares

High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung Pathology
por: Cocconcelli, Elisabetta, et al.
Publicado: (2019)

Heart Failure is Highly Prevalent and Difficult to Diagnose in Severe Exacerbations of COPD Presenting to the Emergency Department
por: Tinè, Mariaenrica, et al.
Publicado: (2020)

Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
por: Biondini, Davide, et al.
Publicado: (2021)

Critical Review of the Evolution of Extracellular Vesicles’ Knowledge: From 1946 to Today
por: Bazzan, Erica, et al.
Publicado: (2021)

Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease
por: Tinè, Mariaenrica, et al.
Publicado: (2019)

Chronic Bronchitis Affects Outcomes in Smokers without Chronic Obstructive Pulmonary Disease (COPD)
por: Casara, Alvise, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
por: Balestro, Elisabetta, et al.
Publicado: (2019)

Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α(1)-Antitrypsin Deficiency
por: Rigobello, Chiara, et al.
Publicado: (2019)

Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
por: Biondini, Davide, et al.
Publicado: (2018)

Radiological Assessment in Idiopathic Pulmonary Fibrosis (IPF) Patients According to MUC5B Polymorphism
por: Cocconcelli, Elisabetta, et al.
Publicado: (2022)

The Role of the Lung’s Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
por: Spagnolo, Paolo, et al.
Publicado: (2019)

Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity
por: Bazzan, Erica, et al.
Publicado: (2017)

Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis
por: Balestro, Elisabetta, et al.
Publicado: (2016)

Macrophages-derived Factor XIII links coagulation to inflammation in COPD
por: Bazzan, Erica, et al.
Publicado: (2023)

Extracellular Vesicles in Lung Cancer: Bystanders or Main Characters?
por: Tinè, Mariaenrica, et al.
Publicado: (2023)

Risk Factors for Development and Severity of COVID-19 in COPD Patients
por: Bonato, Matteo, et al.
Publicado: (2021)

Symptomatic smokers without COPD have physiological changes heralding the development of COPD
por: Bazzan, Erica, et al.
Publicado: (2022)

Clinical Applications of Endobronchial Ultrasound (EBUS) Scope: Challenges and Opportunities
por: Biondini, Davide, et al.
Publicado: (2023)

Pleural clinic: where thoracic ultrasound meets respiratory medicine
por: Tinè, Mariaenrica, et al.
Publicado: (2023)

Early Airway Pathological Changes in Children: New Insights into the Natural History of Wheezing
por: Bonato, Matteo, et al.
Publicado: (2019)

Extracellular Vesicles (EVs) as Crucial Mediators of Cell-Cell Interaction in Asthma
por: Tinè, Mariaenrica, et al.
Publicado: (2023)

Clinical Features and Chest Imaging as Predictors of Intensity of Care in Patients with COVID-19
por: Cocconcelli, Elisabetta, et al.
Publicado: (2020)

CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline
por: Balestro, Elisabetta, et al.
Publicado: (2020)

The Role of Bronchoscopy in the Diagnosis and Management of Patients with SARS-Cov-2 Infection
por: Biondini, Davide, et al.
Publicado: (2021)

The Emerging Role of Extracellular Vesicles Detected in Different Biological Fluids in COPD
por: Neri, Tommaso, et al.
Publicado: (2022)

Do Circulating Extracellular Vesicles Strictly Reflect Bronchoalveolar Lavage Extracellular Vesicles in COPD?
por: Tinè, Mariaenrica, et al.
Publicado: (2023)

Brief communication: Chest radiography score in young COVID-19 patients: Does one size fit all?
por: Castelli, Gioele, et al.
Publicado: (2022)

Characteristics and Prognostic Factors of Pulmonary Fibrosis After COVID-19 Pneumonia
por: Cocconcelli, Elisabetta, et al.
Publicado: (2022)

Extracellular Vesicles in Pulmonary Hypertension: A Dangerous Liaison?
por: Conti, Maria, et al.
Publicado: (2023)

Molecular Mechanism in the Development of Pulmonary Fibrosis in Patients with Sarcoidosis
por: Cocconcelli, Elisabetta, et al.
Publicado: (2023)

Predictors of pulmonary sequelae after COVID-19 pneumonia: A 12-month follow-up study
por: Bernardinello, Nicol, et al.
Publicado: (2023)

Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal Swab
por: Cocconcelli, Elisabetta, et al.
Publicado: (2021)

Pulmonary fibrosis secondary to COVID-19: a call to arms?
por: Spagnolo, Paolo, et al.
Publicado: (2020)

Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis
por: Bernardinello, Nicol, et al.
Publicado: (2021)

CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

ANTIFIBROTIC THERAPY IN IDIOPATHIC PULMONARY FIBROSIS
por: Scullion, T., et al.
Publicado: (2017)

Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics
por: Cottin, Vincent, et al.
Publicado: (2021)

Undifferentiated connective tissue disease presenting with prevalent interstitial lung disease: Case report and review of literature
por: Lunardi, Francesca, et al.
Publicado: (2011)

Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
por: Spagnolo, Paolo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j5niq85bn6vfr6qr84linqb6fh